The medical risk is not hypothetical
ESM Table 7 shows the mean and median proportions of days covered across subgroups of ASCVD status, chronic kidney disease status, heart failure status, BMI category and year of initiation
Foundayo might cost less than an injectable
However, the introduction of GLP-1, a key incretin hormone, has revolutionized the treatment of obesity and T2D
Published qualitative research from the phase 2 trial found that 31 out of 36 retatrutide-treated participants reported meaningful changes in eating behaviors within the first eight weeks of treatment
As your weight changes, your thyroid hormone needs may change too, and Paloma can help you stay on top of lab monitoring with convenient home thyroid testing, symptom checks, and medication adjustments so your treatment plan keeps up with your bodys changes